111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.

111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.

他のバージョン（2件）を表示する

INTRODUCTION: The F3 peptide (KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK), a fragment of the human high mobility group protein 2, binds nucleolin. Nucleolin is expressed in the nuclei of normal cells but is also expressed on the membrane of some cancer cells. The goal was to investigate the use of 111In-labele...

書誌詳細
主要な著者:	Cornelissen, B, Waller, A, Target, C, Kersemans, V, Smart, S, Vallis, K
フォーマット:	Journal article
言語:	English
出版事項:	SpringerOpen 2012

類似資料

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
著者:: Cornelissen, B, 等
出版事項: (2012)

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
著者:: Cornelissen, B, 等
出版事項: (2012)

Auger electron therapy using In-111-labelled F3 peptide
著者:: Cornelissen, B, 等
出版事項: (2011)

Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
著者:: Reilly, R, 等
出版事項: (2006)

Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate.
著者:: Costantini, D, 等
出版事項: (2008)

Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
著者:: Costantini, D, 等
出版事項: (2010)

(111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer.
著者:: Costantini, D, 等
出版事項: (2007)

ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
著者:: Cornelissen, B, 等
出版事項: (2011)

Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
著者:: Bailey, K, 等
出版事項: (2007)

Targeting the nucleus: an overview of Auger-electron radionuclide therapy.
著者:: Cornelissen, B, 等
出版事項: (2010)

Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
著者:: Chen, P, 等
出版事項: (2002)

A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.
著者:: Reilly, R, 等
出版事項: (2004)

Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
著者:: Cai, Z, 等
出版事項: (2008)

The anti-tumor effect of the auger electron-emitting radiopharmaceutical, In-111-hEGF against MDA-MB-468 human breast cancer xenografts is tumor-size dependent.
著者:: Chen, P, 等
出版事項: (2001)

Single cell S-value calculations of a stochastic cascade model for Auger-electron emitting radionuclides
著者:: Vallis, K, 等
出版事項: (2016)

Synthesis and evaluation of an 18F-labeled derivative of F3 for targeting surface expressed nucleolin in cancer and tumor endothelial cells
著者:: Vallis, K, 等
出版事項: (2016)

The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
著者:: Jackson, M
出版事項: (2013)

Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
著者:: Hu, M, 等
出版事項: (2007)

111In-DTPA-Octreotide SPECT (OctreoScan) uptake in metastatic renal cell carcinoma to the pancreas
著者:: Chan, K, 等
出版事項: (2018)

Internalization of Auger electron-emitting isotopes into cancer cells: A method for spatial distribution determination of equivalent source terms
著者:: Vallis, K, 等
出版事項: (2016)

Targeting the oncogenic TBX3:nucleolin complex to treat multiple sarcoma subtypes
著者:: Willmer, T, 等
出版事項: (2021)

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
著者:: McLarty, K, 等
出版事項: (2009)

Towards quantitative intra-nuclear dose mapping of auger emitting radionuclides used for targeted radiotherapy
著者:: Royle, G
出版事項: (2016)

Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.
著者:: Vallis, K, 等
出版事項: (2014)

Absorbed dose evaluation of auger electron-emitting radionuclides: impact of input decay spectra on dose point kernels and S-values
著者:: Falzone, N, 等
出版事項: (2017)

Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software.
著者:: Cai, Z, 等
出版事項: (2009)

Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy
著者:: Terry, S, 等
出版事項: (2012)

Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.
著者:: Terry, S, 等
出版事項: (2012)

Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide.
著者:: Isidori, A, 等
出版事項: (2002)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
著者:: Kaltsas, G, 等
出版事項: (1998)

Photoresists as a high spatial resolution autoradiography substrate for quantitative mapping of intra- and sub-cellular distribution of Auger electron emitting radionuclides.
著者:: Falzone, N, 等
出版事項: (2012)

An approximate analytical solution of the Bethe equation for charged particles in the radiotherapeutic energy range.
著者:: Grimes, D, 等
出版事項: (2017)

Molecular radiotherapy using cleavable radioimmunoconjugates that target eGFR and γH2AX
著者:: Cornelissen, B, 等
出版事項: (2013)

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
著者:: Cornelissen, B, 等
出版事項: (2012)

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
著者:: Cornelissen, B, 等
出版事項: (2012)

SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo
著者:: Song, L, 等
出版事項: (2016)

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
著者:: McLarty, K, 等
出版事項: (2009)

Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
著者:: Cornelissen, B, 等
出版事項: (2013)

Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression
著者:: Zhuang, X, 等
出版事項: (2023)

Moleculary targeted auger electron radiation therapy for breast cancer: A clinical trial.
著者:: Vallis, K, 等
出版事項: (2004)